Washington, D.C. – U.S. Senator Pat Toomey (R-Pa.) issued the following statement regarding the U.S. Trade Representative’s (USTR) announcement that it supports waiving patent protections on COVID-19 vaccines:
“America should help developing nations access, administer, and produce COVID-19 vaccines.
“However, this can be accomplished without forcing American companies to surrender their intellectual property. Vaccine manufacturers and developers are already working with developing nations to expand vaccine production, and waiving intellectual property protections would do nothing to meet the acute need facing these countries. However, it would undermine our ability to meet the next health challenge.
“Developing multiple vaccines at the pace we did was an incredible feat. Other countries in the developed world recognize the role that respect for intellectual property had in this accomplishment and have rejected this waiver proposal. I encourage the Biden administration to drop this plan and instead work with Congress, our allies, and these companies to increase global vaccine distribution while maintaining basic protections for those who worked so hard to make this vaccine possible.”